The effect of gender on the sympathetic nerve hyperactivity of essential hypertension

Journal of Human Hypertension

Volumn 21, Issue 3, 2007, Pages 239-245

  Hogarth, A J ^a   Mackintosh, A F ^a   Mary, D A S G ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; NICOTINE;

ADRENERGIC SYSTEM; ADULT; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; MUSCLE CONTRACTION; NERVE CONDUCTION; NEUROGRAPHY; PERONEUS NERVE; SEX DIFFERENCE; SYMPATHETIC NERVE; SYMPATHETIC TONE;

BLOOD PRESSURE; ELECTROPHYSIOLOGY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; SEX CHARACTERISTICS; SEX FACTORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 33847060915     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002132     Document Type: Article

References (57)

1. Folkow B. Physiological aspect of primary hypertension. Physiol Rev 1982; 62: 347-504.
2. Julius S, Nesbitt S. Sympathetic overactivity in hypertension. A moving target. Am J Hypertens 1996; 9: 113s-120s.
3. Julius S. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension. Eur Heart J 1998; 19(Suppl F): F14-F18.
4. Grassi G. Role of the sympathetic nervous system in human hypertension. J Hypertens 1998; 16: 1979-1987.
5. Jennings GL. Noradrenaline spillover and microneurography measurements in patients with primary hypertension. J Hypertens 1998; 16(Suppl): S35-S38.
6. Greenwood JP, Stoker JB, Mary DASG. Single unit sympathetic discharge: quantitative assessment in human hypertensive disease. Circulation 1999; 100: 1305-1310.
7. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999; 34: 724-728.
8. Esler M. The sympathetic system and hypertension. Am J Hypertens 2000; 13: 99S-105S.
9. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
10. Robitaille NM. Hypertension in women. Can J Cardiol 1996; 12(Suppl D): 6D-8D.
11. Lloyd-Jones DM, Leip EP, Larson MG, Vasan RS, Levy D. Novel approach to examining first cardiovascular events after hypertension onset. Hypertension 2005; 45: 39-45.
12. Isles CG, Hole DJ, Hawthorne VM, Lever AF. Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet 1992; 339: 702-706.
13. Safar ME, Smulyan H. Hypertension in women. Am J Hypertens 2004; 17: 82-87.
14. Mary DA, Stoker JB. The activity of single vasoconstrictor nerve units in hypertension. Acta Physiol Scand 2003; 177: 367-376.
15. Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993; 21: 498-503.
16. Jones PP, Snitker S, Skinner JS, Ravussin E. Gender differences in muscle sympathetic nerve activity: Effect of body fat distribution. Am J Physiol 1996; 270: E363-E366.
17. Matsukawa T, Sugiyarna Y, Watanabe T, Kobayashi F, Mano T. Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects. Am J Physiol 1998; 275: R1600-R1604.
18. Shoemaker JK, Hogeman CS, Khan M, Kimmerly DS, Sinoway LI. Gender affects sympathetic and hemodynamic response to postural stress. Am J Physiol Heart Circ Physiol 2001; 281: H2028-H2035.
19. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 2005; 45: 522-525.
20. Tank J, Diedrich A, Szczech E, Luft FC, Jordan J. Baroreflex regulation of heart rate and sympathetic vasomotor tone in women and men. Hypertension 2005; 45: 1159-1164.
21. Fu Q, Witkowski S, Okazaki K, Levine BD. Effects of gender and hypovolemia on sympathetic neural responses to orthostatic stress. Am J Physiol Regul Integr Comp Physiol 2005; 289: R109-R116.
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252.
23. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Human Hypertens 2004; 18: 139-185.
24. Macefield VG, Wallin BG, Vallbo AB. The discharge behaviour of single vasoconstrictor motoneurones in human muscle nerves. J Physiol (London) 1994; 481: 799-809.
25. Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M. Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 1989; 13: 870-877.
26. Matsukawa T, Gotoh E, Hasegawa O, Shionoiri H, Tochikubo O, Ishii M. Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension. J Hypartens 1991; 9: 537-542.
27. Floras JS, Hera K. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertens 1993; 11: 647-655.
28. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia. G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 31: 68-72.
29. Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary DA. Relationship between central sympathetic activity and stages of human hypertension. Am J Hypertens 2004; 17: 217-222.
30. Calhoun DA, Mutinga ML, Collins AS, Wyss JM, Oparil S. Normotensive blacks have heightened sympathetic response to cold pressor test. Hypertension 1993; 22: 801-805.
31. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence firom direct intraneural recordings. Hypertension 1989; 14: 177-183.
32. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89: 2634-2640.
33. Cox HS, Kaye DM, Thompson JM, Turner AG, Jennings GL, Itsiopoulos C et al. Regional sympathetic nervous activation after a large meal in humans. Clin Sci (Colch) 1995; 89: 145-154.
34. Fagius H, Karhuvaara S. Sympathetic activity and blood pressure increases with bladder distension in humans. Hypertension 1989; 14: 511-517.
35. Sundlöf G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol (London) 1978; 274: 621-637.
36. Skarphedinsson JO, Elam M, Jungersten L, Wallin BG. Sympathetic nerve traffic correlates with the release of nitric oxide in humans: implications for blood pressure control. J Physiol (London) 1997; 501: 671-675.
37. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R et al. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol (London) 1992; 453: 45-58.
38. Wallin BG, Thompson JM, Jennings GL, Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol (London) 1996; 491: 881-887.
39. Kuo TB, Lin T, Yang CC, Li CL, Chen CF, Chou P. Effect of aging on gender differences in neural control of heart rate. Am J Physiol 1999; 277: H2233-H2239.
40. Huikuri HV, Pikkujamsa SM, Airaksinen KE, Ikaheimo MJ, Rantala AO, Kauma H et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation 1996; 94: 122-125.
41. Christou DD, Jones PP, Jordan J, Diedrich A, Robertson D, Seals DR. Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Circulation 2005; 111: 494-498.
42. Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DASG. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 2003; 108: 3097-3101.
43. Huggett RJ, Burns J, Mackintosh AF, Mary DASG. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004; 44: 847-852.
44. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension 1997; 30: 619-623.
45. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Choe I, Winnicki M et al. Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 2001; 19: 1089-1094.
46. Alvarez GE, Ballard TP, Beske SD, Davy KP. Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol 2004; 287: H414-H418.
47. Ettinger SM, Silber DH, Gray KS, Smith MB, Yang QX, Kunselman AR et al. Effects of the ovarian cycle on sympathetic neural outflow during static exercise. J Appl Physiol 1998; 85: 2075-2081.
48. Minson CT, Halliwill JR, Young TM, Joyner MJ. Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 2000; 101: 862-868.
49. Hinojosa-Laborde C, Chapa I, Lange D, Haywood JR. Gender differences in sympathetic nervous system regulation. Clin Exp Pharmacol Physiol 1999; 26: 1440-1681.
50. Barnett SR, Morin RJ, Kiely DK, Gagnon M, Azhar G, Knight EL et al. Effects of age and gender on autonomic control of blood pressure dynamics. Hypertension 1999; 33: 1195-1200.
51. Stramba-Badiale M, Fox KM, Priori SG, Collins P, Daly C, Graham I et al. Cardiovascular diseases in women: A statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006; 27: 994-1005.
52. Grassi G, Seravalle G, Turri C, Bolla G, Mancia G. Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension. Hypertension 2003; 41: 558-562.
53. Binggeli C, Corti R, Sudano I, Luscher TF, Noll G. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension. Hypertension 2002; 39: 892-896.
54. Struck J, Muck P, Trubger D, Handrock R, Weidinger G, Dendorfer A et al. Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J Hypertens 2002; 20: 1143-1149.
55. Grassi G, Turri C, Dell'Oro R, Stella ML, Bolla GB, Mancia G. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. J Hypertens 1998; 16: 1789-1796.
56. Burns J, Mary DASG, Mackintosh AF, Ball SG, Greenwood JP. Arterial pressure lowering effect of chronic atenolol therapy in hypertension and vasoconstrictor sympathetic drive. Hypertension 2004; 44: 454-458.
57. Greenwood JP, Scott EM, Stoker JB, Mary DA. Chronic I(1)-imidazoline agonism: Sympathetic mechanisms in hypertension. Hypertension 2000; 35: 1264-1269.